nodes	percent_of_prediction	percent_of_DWPC	metapath
Pasireotide—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.0125	0.0531	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Vemurafenib—melanoma	0.00978	0.0414	CcSEcCtD
Pasireotide—Pain in extremity—Vemurafenib—melanoma	0.00584	0.0247	CcSEcCtD
Pasireotide—Dry skin—Vemurafenib—melanoma	0.00536	0.0227	CcSEcCtD
Pasireotide—Gamma-glutamyltransferase increased—Temozolomide—melanoma	0.005	0.0212	CcSEcCtD
Pasireotide—Injection site reaction—Carmustine—melanoma	0.00423	0.0179	CcSEcCtD
Pasireotide—Oedema peripheral—Vemurafenib—melanoma	0.00398	0.0169	CcSEcCtD
Pasireotide—Alopecia—Vemurafenib—melanoma	0.00357	0.0151	CcSEcCtD
Pasireotide—Diabetes mellitus—Carmustine—melanoma	0.00355	0.015	CcSEcCtD
Pasireotide—Back pain—Vemurafenib—melanoma	0.0034	0.0144	CcSEcCtD
Pasireotide—Arthralgia—Vemurafenib—melanoma	0.003	0.0127	CcSEcCtD
Pasireotide—Myalgia—Vemurafenib—melanoma	0.003	0.0127	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00297	0.0126	CcSEcCtD
Pasireotide—Hypokalaemia—Carmustine—melanoma	0.00281	0.0119	CcSEcCtD
Pasireotide—Dry skin—Temozolomide—melanoma	0.00274	0.0116	CcSEcCtD
Pasireotide—Injection site reaction—Docetaxel—melanoma	0.00272	0.0115	CcSEcCtD
Pasireotide—Hypokalaemia—Temozolomide—melanoma	0.00272	0.0115	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00269	0.0114	CcSEcCtD
Pasireotide—Hypotension—Vemurafenib—melanoma	0.00268	0.0114	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Temozolomide—melanoma	0.00263	0.0112	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00262	0.0111	CcSEcCtD
Pasireotide—Abdominal distension—Temozolomide—melanoma	0.0026	0.011	CcSEcCtD
Pasireotide—Decreased appetite—Vemurafenib—melanoma	0.0025	0.0106	CcSEcCtD
Pasireotide—Fatigue—Vemurafenib—melanoma	0.00248	0.0105	CcSEcCtD
Pasireotide—Constipation—Vemurafenib—melanoma	0.00246	0.0104	CcSEcCtD
Pasireotide—Hyperglycaemia—Carmustine—melanoma	0.00241	0.0102	CcSEcCtD
Pasireotide—Hyperglycaemia—Temozolomide—melanoma	0.00233	0.00986	CcSEcCtD
Pasireotide—Alopecia—Bleomycin—melanoma	0.00216	0.00916	CcSEcCtD
Pasireotide—Oedema peripheral—Carmustine—melanoma	0.00211	0.00892	CcSEcCtD
Pasireotide—Asthenia—Vemurafenib—melanoma	0.00206	0.00873	CcSEcCtD
Pasireotide—Oedema peripheral—Temozolomide—melanoma	0.00203	0.00862	CcSEcCtD
Pasireotide—Pruritus—Vemurafenib—melanoma	0.00203	0.0086	CcSEcCtD
Pasireotide—Alopecia—Dactinomycin—melanoma	0.00202	0.00855	CcSEcCtD
Pasireotide—Pain in extremity—Docetaxel—melanoma	0.00199	0.00841	CcSEcCtD
Pasireotide—Anaemia—Bleomycin—melanoma	0.00197	0.00834	CcSEcCtD
Pasireotide—Diarrhoea—Vemurafenib—melanoma	0.00196	0.00832	CcSEcCtD
Pasireotide—Dizziness—Vemurafenib—melanoma	0.0019	0.00804	CcSEcCtD
Pasireotide—Alopecia—Carmustine—melanoma	0.00189	0.008	CcSEcCtD
Pasireotide—Anaemia—Dactinomycin—melanoma	0.00184	0.00778	CcSEcCtD
Pasireotide—Vomiting—Vemurafenib—melanoma	0.00183	0.00773	CcSEcCtD
Pasireotide—Alopecia—Temozolomide—melanoma	0.00183	0.00773	CcSEcCtD
Pasireotide—Dry skin—Docetaxel—melanoma	0.00182	0.00771	CcSEcCtD
Pasireotide—Myalgia—Bleomycin—melanoma	0.00181	0.00769	CcSEcCtD
Pasireotide—Abdominal pain upper—Docetaxel—melanoma	0.00181	0.00768	CcSEcCtD
Pasireotide—Back pain—Carmustine—melanoma	0.0018	0.00762	CcSEcCtD
Pasireotide—Headache—Vemurafenib—melanoma	0.0018	0.00762	CcSEcCtD
Pasireotide—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00179	0.00757	CcSEcCtD
Pasireotide—Nasopharyngitis—Docetaxel—melanoma	0.00178	0.00752	CcSEcCtD
Pasireotide—Alanine aminotransferase increased—Docetaxel—melanoma	0.00175	0.00742	CcSEcCtD
Pasireotide—Back pain—Temozolomide—melanoma	0.00174	0.00737	CcSEcCtD
Pasireotide—Anaemia—Carmustine—melanoma	0.00172	0.00728	CcSEcCtD
Pasireotide—Nausea—Vemurafenib—melanoma	0.00171	0.00722	CcSEcCtD
Pasireotide—Myalgia—Dactinomycin—melanoma	0.00169	0.00717	CcSEcCtD
Pasireotide—Anaemia—Temozolomide—melanoma	0.00166	0.00704	CcSEcCtD
Pasireotide—Hypotension—Bleomycin—melanoma	0.00163	0.00688	CcSEcCtD
Pasireotide—Vertigo—Temozolomide—melanoma	0.00162	0.00684	CcSEcCtD
Pasireotide—Hypertension—Carmustine—melanoma	0.00161	0.0068	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00158	0.00671	CcSEcCtD
Pasireotide—Myalgia—Carmustine—melanoma	0.00158	0.00671	CcSEcCtD
Pasireotide—Anxiety—Carmustine—melanoma	0.00158	0.00669	CcSEcCtD
Pasireotide—Hypertension—Temozolomide—melanoma	0.00155	0.00657	CcSEcCtD
Pasireotide—Arthralgia—Temozolomide—melanoma	0.00153	0.00648	CcSEcCtD
Pasireotide—Myalgia—Temozolomide—melanoma	0.00153	0.00648	CcSEcCtD
Pasireotide—Anxiety—Temozolomide—melanoma	0.00153	0.00646	CcSEcCtD
Pasireotide—Decreased appetite—Bleomycin—melanoma	0.00151	0.0064	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00148	0.00626	CcSEcCtD
Pasireotide—Hypotension—Carmustine—melanoma	0.00142	0.00601	CcSEcCtD
Pasireotide—Decreased appetite—Dactinomycin—melanoma	0.00141	0.00597	CcSEcCtD
Pasireotide—Fatigue—Dactinomycin—melanoma	0.0014	0.00592	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Carmustine—melanoma	0.00138	0.00586	CcSEcCtD
Pasireotide—Insomnia—Carmustine—melanoma	0.00137	0.00582	CcSEcCtD
Pasireotide—Oedema peripheral—Docetaxel—melanoma	0.00135	0.00573	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00134	0.00566	CcSEcCtD
Pasireotide—Insomnia—Temozolomide—melanoma	0.00133	0.00562	CcSEcCtD
Pasireotide—Gastrointestinal pain—Dactinomycin—melanoma	0.00133	0.00562	CcSEcCtD
Pasireotide—Decreased appetite—Carmustine—melanoma	0.00132	0.00559	CcSEcCtD
Pasireotide—Constipation—Carmustine—melanoma	0.0013	0.0055	CcSEcCtD
Pasireotide—Abdominal pain—Dactinomycin—melanoma	0.00128	0.00543	CcSEcCtD
Pasireotide—Decreased appetite—Temozolomide—melanoma	0.00128	0.0054	CcSEcCtD
Pasireotide—Fatigue—Temozolomide—melanoma	0.00127	0.00536	CcSEcCtD
Pasireotide—Constipation—Temozolomide—melanoma	0.00125	0.00531	CcSEcCtD
Pasireotide—Asthenia—Bleomycin—melanoma	0.00125	0.00529	CcSEcCtD
Pasireotide—Gastrointestinal pain—Carmustine—melanoma	0.00124	0.00526	CcSEcCtD
Pasireotide—Pruritus—Bleomycin—melanoma	0.00123	0.00521	CcSEcCtD
Pasireotide—Alopecia—Docetaxel—melanoma	0.00121	0.00514	CcSEcCtD
Pasireotide—Abdominal pain—Carmustine—melanoma	0.0012	0.00508	CcSEcCtD
Pasireotide—Gastrointestinal pain—Temozolomide—melanoma	0.0012	0.00508	CcSEcCtD
Pasireotide—Asthenia—Dactinomycin—melanoma	0.00116	0.00493	CcSEcCtD
Pasireotide—Abdominal pain—Temozolomide—melanoma	0.00116	0.00491	CcSEcCtD
Pasireotide—Back pain—Docetaxel—melanoma	0.00116	0.0049	CcSEcCtD
Pasireotide—Diarrhoea—Dactinomycin—melanoma	0.00111	0.0047	CcSEcCtD
Pasireotide—Vomiting—Bleomycin—melanoma	0.00111	0.00468	CcSEcCtD
Pasireotide—Anaemia—Docetaxel—melanoma	0.00111	0.00468	CcSEcCtD
Pasireotide—Asthenia—Carmustine—melanoma	0.00109	0.00461	CcSEcCtD
Pasireotide—Asthenia—Temozolomide—melanoma	0.00105	0.00446	CcSEcCtD
Pasireotide—Diarrhoea—Carmustine—melanoma	0.00104	0.0044	CcSEcCtD
Pasireotide—Pruritus—Temozolomide—melanoma	0.00104	0.0044	CcSEcCtD
Pasireotide—Nausea—Bleomycin—melanoma	0.00103	0.00438	CcSEcCtD
Pasireotide—Hypertension—Docetaxel—melanoma	0.00103	0.00437	CcSEcCtD
Pasireotide—Vomiting—Dactinomycin—melanoma	0.00103	0.00437	CcSEcCtD
Pasireotide—Myalgia—Docetaxel—melanoma	0.00102	0.00431	CcSEcCtD
Pasireotide—Arthralgia—Docetaxel—melanoma	0.00102	0.00431	CcSEcCtD
Pasireotide—Dizziness—Carmustine—melanoma	0.001	0.00425	CcSEcCtD
Pasireotide—Diarrhoea—Temozolomide—melanoma	0.001	0.00425	CcSEcCtD
Pasireotide—Dizziness—Temozolomide—melanoma	0.00097	0.00411	CcSEcCtD
Pasireotide—Vomiting—Carmustine—melanoma	0.000966	0.00409	CcSEcCtD
Pasireotide—Nausea—Dactinomycin—melanoma	0.000964	0.00408	CcSEcCtD
Pasireotide—Headache—Carmustine—melanoma	0.000951	0.00403	CcSEcCtD
Pasireotide—Vomiting—Temozolomide—melanoma	0.000933	0.00395	CcSEcCtD
Pasireotide—Headache—Temozolomide—melanoma	0.000919	0.00389	CcSEcCtD
Pasireotide—Hypotension—Docetaxel—melanoma	0.000912	0.00386	CcSEcCtD
Pasireotide—Nausea—Carmustine—melanoma	0.000902	0.00382	CcSEcCtD
Pasireotide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000889	0.00377	CcSEcCtD
Pasireotide—Insomnia—Docetaxel—melanoma	0.000883	0.00374	CcSEcCtD
Pasireotide—Nausea—Temozolomide—melanoma	0.000872	0.00369	CcSEcCtD
Pasireotide—Decreased appetite—Docetaxel—melanoma	0.000848	0.00359	CcSEcCtD
Pasireotide—Fatigue—Docetaxel—melanoma	0.000841	0.00356	CcSEcCtD
Pasireotide—Constipation—Docetaxel—melanoma	0.000835	0.00353	CcSEcCtD
Pasireotide—Gastrointestinal pain—Docetaxel—melanoma	0.000798	0.00338	CcSEcCtD
Pasireotide—Abdominal pain—Docetaxel—melanoma	0.000771	0.00327	CcSEcCtD
Pasireotide—Asthenia—Docetaxel—melanoma	0.0007	0.00297	CcSEcCtD
Pasireotide—Pruritus—Docetaxel—melanoma	0.00069	0.00292	CcSEcCtD
Pasireotide—Diarrhoea—Docetaxel—melanoma	0.000668	0.00283	CcSEcCtD
Pasireotide—Dizziness—Docetaxel—melanoma	0.000645	0.00273	CcSEcCtD
Pasireotide—Vomiting—Docetaxel—melanoma	0.00062	0.00263	CcSEcCtD
Pasireotide—Headache—Docetaxel—melanoma	0.000611	0.00259	CcSEcCtD
Pasireotide—Nausea—Docetaxel—melanoma	0.00058	0.00246	CcSEcCtD
Pasireotide—SSTR3—Signaling Pathways—TERT—melanoma	0.000175	0.00023	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—RAC1—melanoma	0.000175	0.000229	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SOCS1—melanoma	0.000174	0.000228	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAP2K1—melanoma	0.000174	0.000227	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—S100B—melanoma	0.000174	0.000227	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CD—melanoma	0.000173	0.000226	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD86—melanoma	0.000173	0.000226	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—CXCL8—melanoma	0.000173	0.000226	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EDN1—melanoma	0.000171	0.000224	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL2—melanoma	0.000169	0.000221	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TERT—melanoma	0.000168	0.00022	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HIF1A—melanoma	0.000168	0.00022	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—RAC1—melanoma	0.000168	0.00022	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGF1—melanoma	0.000167	0.000219	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CSF2—melanoma	0.000167	0.000219	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB4—melanoma	0.000166	0.000217	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CB—melanoma	0.000166	0.000217	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—IL2—melanoma	0.000165	0.000216	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN2B—melanoma	0.000165	0.000216	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—E2F1—melanoma	0.000164	0.000214	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CB—melanoma	0.000163	0.000213	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PDGFRA—melanoma	0.000162	0.000212	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HIF1A—melanoma	0.000161	0.000211	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KDR—melanoma	0.00016	0.00021	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PRKCA—melanoma	0.00016	0.00021	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ITGB3—melanoma	0.00016	0.00021	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD86—melanoma	0.000159	0.000209	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—CXCL8—melanoma	0.000159	0.000208	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EDN1—melanoma	0.000158	0.000207	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—SPP1—melanoma	0.000157	0.000206	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAP2K2—melanoma	0.000157	0.000205	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—CXCL8—melanoma	0.000157	0.000205	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF1—melanoma	0.000154	0.000202	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FN1—melanoma	0.000154	0.000202	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CSF2—melanoma	0.000154	0.000202	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KDR—melanoma	0.000154	0.000201	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—IL2—melanoma	0.000152	0.000199	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NOTCH1—melanoma	0.000151	0.000198	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—E2F1—melanoma	0.000151	0.000198	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CB—melanoma	0.00015	0.000197	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL2—melanoma	0.00015	0.000196	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PDGFRA—melanoma	0.00015	0.000196	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TERT—melanoma	0.000149	0.000195	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—RAC1—melanoma	0.000149	0.000195	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FN1—melanoma	0.000148	0.000194	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ITGB3—melanoma	0.000148	0.000194	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PRKCA—melanoma	0.000148	0.000194	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CD80—melanoma	0.000148	0.000194	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CG—melanoma	0.000148	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KIT—melanoma	0.000148	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—APC—melanoma	0.000148	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—NRAS—melanoma	0.000148	0.000193	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGF—melanoma	0.000146	0.000191	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—SPP1—melanoma	0.000145	0.00019	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NOTCH1—melanoma	0.000145	0.00019	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAP2K2—melanoma	0.000145	0.000189	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—CXCL8—melanoma	0.000145	0.000189	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HIF1A—melanoma	0.000143	0.000187	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CD80—melanoma	0.000142	0.000186	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CG—melanoma	0.000142	0.000186	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—APC—melanoma	0.000142	0.000186	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KIT—melanoma	0.000142	0.000186	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—NRAS—melanoma	0.000142	0.000186	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK3—melanoma	0.000142	0.000185	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGF—melanoma	0.00014	0.000183	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—BRAF—melanoma	0.000139	0.000182	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL2—melanoma	0.000138	0.000181	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TERT—melanoma	0.000138	0.00018	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—RAC1—melanoma	0.000137	0.00018	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KDR—melanoma	0.000136	0.000179	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK3—melanoma	0.000136	0.000178	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IGF1—melanoma	0.000135	0.000177	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—MAPK1—melanoma	0.000135	0.000176	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—EGFR—melanoma	0.000135	0.000176	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—BRAF—melanoma	0.000133	0.000174	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HIF1A—melanoma	0.000132	0.000172	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FN1—melanoma	0.000131	0.000172	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAP2K1—melanoma	0.000131	0.000171	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CD—melanoma	0.00013	0.00017	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IGF1—melanoma	0.00013	0.00017	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—MAPK1—melanoma	0.000129	0.000169	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—EGFR—melanoma	0.000129	0.000169	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—PIK3CA—melanoma	0.000129	0.000168	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NOTCH1—melanoma	0.000129	0.000168	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—KRAS—melanoma	0.000127	0.000167	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KDR—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CD80—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CG—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—APC—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KIT—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—NRAS—melanoma	0.000126	0.000165	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAP2K1—melanoma	0.000125	0.000164	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CD—melanoma	0.000125	0.000163	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—FGF2—melanoma	0.000124	0.000163	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGF—melanoma	0.000124	0.000163	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—PIK3CA—melanoma	0.000123	0.000162	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—KRAS—melanoma	0.000122	0.00016	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FN1—melanoma	0.000121	0.000159	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK3—melanoma	0.00012	0.000158	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—FGF2—melanoma	0.000119	0.000156	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NOTCH1—melanoma	0.000119	0.000155	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—BRAF—melanoma	0.000118	0.000155	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—PIK3CA—melanoma	0.000117	0.000153	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MDM2—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CD80—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CG—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KIT—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—APC—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—NRAS—melanoma	0.000116	0.000152	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IGF1—melanoma	0.000115	0.000151	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—ERBB2—melanoma	0.000115	0.00015	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGF—melanoma	0.000115	0.00015	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—MAPK1—melanoma	0.000115	0.00015	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—EGFR—melanoma	0.000115	0.00015	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CB—melanoma	0.000113	0.000148	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—PIK3CA—melanoma	0.000112	0.000147	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MDM2—melanoma	0.000112	0.000146	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAP2K1—melanoma	0.000111	0.000146	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK3—melanoma	0.000111	0.000145	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CD—melanoma	0.00011	0.000145	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—ERBB2—melanoma	0.00011	0.000144	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—PIK3CA—melanoma	0.000109	0.000143	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—BRAF—melanoma	0.000109	0.000143	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CXCL8—melanoma	0.000109	0.000142	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CB—melanoma	0.000109	0.000142	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—KRAS—melanoma	0.000108	0.000142	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—HRAS—melanoma	0.000108	0.000142	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1B—melanoma	0.000106	0.000139	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IGF1—melanoma	0.000106	0.000139	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—FGF2—melanoma	0.000106	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—MAPK1—melanoma	0.000106	0.000138	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—EGFR—melanoma	0.000106	0.000138	CbGpPWpGaD
Pasireotide—SSTR3—GPCR downstream signaling—AKT1—melanoma	0.000105	0.000138	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CXCL8—melanoma	0.000104	0.000137	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CASP3—melanoma	0.000104	0.000136	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL2—melanoma	0.000104	0.000136	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—HRAS—melanoma	0.000104	0.000136	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—IL6—melanoma	0.000103	0.000135	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAP2K1—melanoma	0.000103	0.000134	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CD—melanoma	0.000102	0.000133	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1B—melanoma	0.000102	0.000133	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CCND1—melanoma	0.000101	0.000133	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—PIK3CA—melanoma	0.000101	0.000132	CbGpPWpGaD
Pasireotide—SSTR1—GPCR downstream signaling—AKT1—melanoma	0.000101	0.000132	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CTNNB1—melanoma	0.0001	0.000131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CASP3—melanoma	9.99e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—KRAS—melanoma	9.98e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL2—melanoma	9.97e-05	0.000131	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—PIK3CA—melanoma	9.94e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—IL6—melanoma	9.92e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MDM2—melanoma	9.9e-05	0.00013	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MMP9—melanoma	9.84e-05	0.000129	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—CDKN1A—melanoma	9.81e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PTEN—melanoma	9.79e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—FGF2—melanoma	9.76e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—ERBB2—melanoma	9.76e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NFKB1—melanoma	9.74e-05	0.000128	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CCND1—melanoma	9.72e-05	0.000127	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CB—melanoma	9.63e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CTNNB1—melanoma	9.63e-05	0.000126	CbGpPWpGaD
Pasireotide—SSTR3—Signaling by GPCR—AKT1—melanoma	9.55e-05	0.000125	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MMP9—melanoma	9.44e-05	0.000124	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—CDKN1A—melanoma	9.4e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PTEN—melanoma	9.38e-05	0.000123	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NFKB1—melanoma	9.34e-05	0.000122	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CXCL8—melanoma	9.25e-05	0.000121	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—HRAS—melanoma	9.19e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—PIK3CA—melanoma	9.17e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR1—Signaling by GPCR—AKT1—melanoma	9.15e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MDM2—melanoma	9.13e-05	0.00012	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1B—melanoma	9.04e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—ERBB2—melanoma	9.01e-05	0.000118	CbGpPWpGaD
Pasireotide—SSTR5—GPCR downstream signaling—AKT1—melanoma	8.94e-05	0.000117	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CB—melanoma	8.89e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CASP3—melanoma	8.86e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL2—melanoma	8.84e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—VEGFA—melanoma	8.84e-05	0.000116	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—IL6—melanoma	8.8e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—STAT3—melanoma	8.75e-05	0.000115	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—NRAS—melanoma	8.73e-05	0.000114	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CCND1—melanoma	8.62e-05	0.000113	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CXCL8—melanoma	8.54e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CTNNB1—melanoma	8.54e-05	0.000112	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—HRAS—melanoma	8.49e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—VEGFA—melanoma	8.47e-05	0.000111	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—STAT3—melanoma	8.39e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—NRAS—melanoma	8.37e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MMP9—melanoma	8.37e-05	0.00011	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK3—melanoma	8.36e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—CDKN1A—melanoma	8.34e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1B—melanoma	8.34e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PTEN—melanoma	8.32e-05	0.000109	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NFKB1—melanoma	8.28e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR2—GPCR downstream signaling—AKT1—melanoma	8.25e-05	0.000108	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CASP3—melanoma	8.17e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL2—melanoma	8.16e-05	0.000107	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MYC—melanoma	8.13e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—IL6—melanoma	8.12e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR5—Signaling by GPCR—AKT1—melanoma	8.12e-05	0.000106	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK3—melanoma	8.02e-05	0.000105	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—MAPK1—melanoma	7.96e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CCND1—melanoma	7.96e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—EGFR—melanoma	7.96e-05	0.000104	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CTNNB1—melanoma	7.88e-05	0.000103	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MYC—melanoma	7.8e-05	0.000102	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MMP9—melanoma	7.72e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—CDKN1A—melanoma	7.7e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PTEN—melanoma	7.68e-05	0.000101	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NFKB1—melanoma	7.64e-05	0.0001	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—MAPK1—melanoma	7.63e-05	9.99e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—EGFR—melanoma	7.63e-05	9.98e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—VEGFA—melanoma	7.52e-05	9.84e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—KRAS—melanoma	7.51e-05	9.84e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling by GPCR—AKT1—melanoma	7.49e-05	9.81e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—STAT3—melanoma	7.44e-05	9.74e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—NRAS—melanoma	7.42e-05	9.72e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—KRAS—melanoma	7.2e-05	9.43e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK3—melanoma	7.11e-05	9.31e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—VEGFA—melanoma	6.94e-05	9.08e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MYC—melanoma	6.92e-05	9.05e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—PIK3CA—melanoma	6.9e-05	9.04e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—STAT3—melanoma	6.87e-05	8.99e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—NRAS—melanoma	6.85e-05	8.97e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—MAPK1—melanoma	6.77e-05	8.86e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—EGFR—melanoma	6.76e-05	8.85e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—TP53—melanoma	6.68e-05	8.74e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—PIK3CA—melanoma	6.62e-05	8.67e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK3—melanoma	6.56e-05	8.59e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—TP53—melanoma	6.4e-05	8.38e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—KRAS—melanoma	6.39e-05	8.36e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—HRAS—melanoma	6.39e-05	8.36e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MYC—melanoma	6.38e-05	8.35e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—MAPK1—melanoma	6.24e-05	8.17e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—EGFR—melanoma	6.24e-05	8.17e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—HRAS—melanoma	6.12e-05	8.02e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—IL6—melanoma	6.11e-05	8e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—KRAS—melanoma	5.9e-05	7.72e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—PIK3CA—melanoma	5.87e-05	7.69e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—IL6—melanoma	5.86e-05	7.67e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—TP53—melanoma	5.68e-05	7.43e-05	CbGpPWpGaD
Pasireotide—SSTR3—Signaling Pathways—AKT1—melanoma	5.64e-05	7.38e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—HRAS—melanoma	5.43e-05	7.11e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—PIK3CA—melanoma	5.42e-05	7.09e-05	CbGpPWpGaD
Pasireotide—SSTR1—Signaling Pathways—AKT1—melanoma	5.41e-05	7.08e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—TP53—melanoma	5.24e-05	6.86e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—IL6—melanoma	5.2e-05	6.81e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—HRAS—melanoma	5.01e-05	6.56e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—IL6—melanoma	4.8e-05	6.28e-05	CbGpPWpGaD
Pasireotide—SSTR5—Signaling Pathways—AKT1—melanoma	4.8e-05	6.28e-05	CbGpPWpGaD
Pasireotide—SSTR2—Signaling Pathways—AKT1—melanoma	4.43e-05	5.79e-05	CbGpPWpGaD
